NYSE: UNH
Unitedhealth Group Inc Stock

$503.80+4.78 (+0.96%)
Updated Mar 18, 2025
UNH Price
$503.80
Fair Value Price
N/A
Market Cap
$460.83B
52 Week Low
$436.38
52 Week High
$630.73
P/E
32.21x
P/B
4.97x
P/S
1.16x
PEG
0.97x
Dividend Yield
1.67%
Revenue
$400.28B
Earnings
$14.41B
Gross Margin
22.3%
Operating Margin
5.78%
Profit Margin
3.6%
Debt to Equity
2.11
Operating Cash Flow
$24B
Beta
0.68
Next Earnings
Apr 14, 2025
Ex-Dividend
N/A
Next Dividend
N/A

UNH Overview

UnitedHealth Group Incorporated offers health benefit plans and services for employers, public sector employers, small businesses, and individuals. Its OptumHealth segment provides access to networks of specialists, health management services, and financial services. OptumInsight offers software products, consulting, and outsourcing to hospitals, physicians, and related organizations. OptumRx provides pharmacy services and programs. The company was incorporated in 1977 and is based in Minnetonka, MN.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine UNH's potential to beat the market

BBuy
  • Stocks with a Zen Rating of Buy (B) had an average return of +19.88% per year. Learn More

Zen Rating Component Grades

B
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Healthcare Plan

Industry Rating
A
UNH
Ranked
#1 of 10

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
$322.43B
$59.66B
$436.25C
View Top Healthcare Plan Stocks

Be the first to know about important UNH news, forecast changes, insider trades & much more!

UNH News

Overview

Due Diligence Score

Industry Average (39)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how UNH scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

UNH ($503.80) is trading above its intrinsic value of $266.36, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
UNH is poor value based on its earnings relative to its share price (32.21x), compared to the US market average (30.9x)
P/E vs Market Valuation
UNH is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more UNH due diligence checks available for Premium users.

Valuation

UNH price to earnings (PE)

For valuing profitable companies with steady earnings

Company
32.21x
Industry
26.84x
Market
30.9x
UNH is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
UNH is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation

UNH price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
4.97x
Industry
2.76x
UNH is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

UNH price to earnings growth (PEG)

For valuing profitable companies with growth potential

UNH is good value based... subscribe to Premium to read more.
PEG Value Valuation

UNH's financial health

Profit margin

Revenue
$100.8B
Net Income
$5.5B
Profit Margin
5.5%
UNH's Earnings (EBIT) of $23.14B... subscribe to Premium to read more.
Interest Coverage Financials
UNH's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$298.3B
Liabilities
$195.7B
Debt to equity
2.11
UNH's short-term liabilities ($103.77B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
UNH's long-term liabilities ($91.92B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
UNH's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
UNH's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$2.4B
Investing
-$1.1B
Financing
-$8.3B
UNH's operating cash flow ($24.20B)... subscribe to Premium to read more.
Debt Coverage Financials

UNH vs Healthcare Plan Stocks

TickerZen RatingMarket Cap1d %P/EP/B
UNHB$460.83B+0.96%32.21x4.97x
ELVC$99.18B+1.31%16.90x2.40x
CIB$88.24B+1.78%26.32x2.15x
CVSC$85.19B+1.38%18.41x1.13x
HUMC$32.55B+2.03%26.95x1.99x

Unitedhealth Group Stock FAQ

What is Unitedhealth Group's quote symbol?

(NYSE: UNH) Unitedhealth Group trades on the NYSE under the ticker symbol UNH. Unitedhealth Group stock quotes can also be displayed as NYSE: UNH.

If you're new to stock investing, here's how to buy Unitedhealth Group stock.

What is the 52 week high and low for Unitedhealth Group (NYSE: UNH)?

(NYSE: UNH) Unitedhealth Group's 52-week high was $630.73, and its 52-week low was $436.38. It is currently -20.12% from its 52-week high and 15.45% from its 52-week low.

How much is Unitedhealth Group stock worth today?

(NYSE: UNH) Unitedhealth Group currently has 914,712,333 outstanding shares. With Unitedhealth Group stock trading at $503.80 per share, the total value of Unitedhealth Group stock (market capitalization) is $460.83B.

Unitedhealth Group stock was originally listed at a price of $6.21 in Dec 31, 1997. If you had invested in Unitedhealth Group stock at $6.21, your return over the last 27 years would have been 8,011.42%, for an annualized return of 17.68% (not including any dividends or dividend reinvestments).

How much is Unitedhealth Group's stock price per share?

(NYSE: UNH) Unitedhealth Group stock price per share is $503.80 today (as of Mar 18, 2025).

What is Unitedhealth Group's Market Cap?

(NYSE: UNH) Unitedhealth Group's market cap is $460.83B, as of Mar 19, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Unitedhealth Group's market cap is calculated by multiplying UNH's current stock price of $503.80 by UNH's total outstanding shares of 914,712,333.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.